Literature DB >> 18253762

Development of an experimental hemolytic uremic syndrome in rats.

Elsa Zotta1, Nestor Lago, Federico Ochoa, Horacio A Repetto, Cristina Ibarra.   

Abstract

Escherichia coli strains producing Shiga toxins (Stxs) colonize the lower gastrointestinal tract and cause watery diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome (HUS). HUS is characterized by hemolytic anemia, thrombocytopenia, and acute renal failure. Oliguria associated with acute tubular necrosis and microangiopathic thrombosis has been reported as the most common cause of renal failure in Argentinean children. Our study was undertaken to obtain a model of HUS in rats that was similar to the clinical and renal histopathology findings described in humans. Rats were intraperitoneally inoculated with culture supernatant from recombinant E. coli expressing Stx2. Glomerular filtrate volume evaluated from clearance of creatinine resulted in a progressive reduction (from 53% at 24 h to 90% at 48 h). Urine volume increased significantly at 24 h but returned to normal levels at 48 h. Evidence of thrombocytopenia, anemia and leukocytosis was documented. Macroscopic analysis revealed a hyperemic peritoneal face with intestinal water accumulation. The kidneys were friable and congestive. Histopathological analysis showed glomerular and tubular necrosis as well as microangiopathic thrombosis. Our findings indicated vascular damage and kidney lesions similar to those described in humans with HUS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253762     DOI: 10.1007/s00467-007-0727-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  34 in total

1.  Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.

Authors:  J F Pohlenz; K R Winter; E A Dean-Nystrom
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Epidemic hemolytic-uremic syndrome in children.

Authors:  H A Repetto
Journal:  Kidney Int       Date:  1997-12       Impact factor: 10.612

Review 3.  Microangiopathic hemolytic anemia.

Authors:  M C Brain
Journal:  Annu Rev Med       Date:  1970       Impact factor: 13.739

4.  Response to Shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome.

Authors:  R L Siegler; T J Pysher; R Lou; V L Tesh; F B Taylor
Journal:  Am J Nephrol       Date:  2001 Sep-Oct       Impact factor: 3.754

Review 5.  Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.

Authors:  P Ruggenenti; M Noris; G Remuzzi
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

6.  Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality.

Authors:  M Palermo; F Alves-Rosa; C Rubel; G C Fernández; G Fernández-Alonso; F Alberto; M Rivas; M Isturiz
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

7.  Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E coli strains in neonatal pigs.

Authors:  Evelyn A Dean-Nystrom; Angela R Melton-Celsa; Joachim F L Pohlenz; Harley W Moon; Alison D O'Brien
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Restricted expression of shiga toxin binding sites on mucosal epithelium of mouse distal colon.

Authors:  Yasuyuki Imai; Takashi Fukui; Kohta Kurohane; Daisei Miyamoto; Yasuo Suzuki; Tomoyuki Ishikawa; Yousuke Ono; Masaki Miyake
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

Review 9.  Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection.

Authors:  P I Tarr
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079

10.  Home-prepared hamburger and sporadic hemolytic uremic syndrome, Argentina.

Authors:  Marta Rivas; María Gracia Caletti; Isabel Chinen; Stella Maris Refi; Carlos Daniel Roldán; Germán Chillemi; Graciela Fiorilli; Alicia Bertolotti; Lorena Aguerre; Sergio Sosa Estani
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

View more
  11 in total

1.  Introduction: education teaching article series on hemolytic uremic syndrome.

Authors:  Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2008-06-06       Impact factor: 3.714

Review 2.  Bacterial Chat: Intestinal Metabolites and Signals in Host-Microbiota-Pathogen Interactions.

Authors:  Bruna C Lustri; Vanessa Sperandio; Cristiano G Moreira
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

3.  Shiga toxin subtypes display dramatic differences in potency.

Authors:  Cynthia A Fuller; Christine A Pellino; Michael J Flagler; Jane E Strasser; Alison A Weiss
Journal:  Infect Immun       Date:  2011-01-03       Impact factor: 3.441

Review 4.  Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection.

Authors:  Victor A Garcia-Angulo; Anjana Kalita; Alfredo G Torres
Journal:  Vaccine       Date:  2013-05-22       Impact factor: 3.641

5.  Role of nitric oxide in shiga toxin-2-induced premature delivery of dead fetuses in rats.

Authors:  Juliana Burdet; Elsa Zotta; Maximiliano Cella; Ana M Franchi; Cristina Ibarra
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

Review 6.  Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection.

Authors:  Krystle L Mohawk; Alison D O'Brien
Journal:  J Biomed Biotechnol       Date:  2011-01-03

7.  Microalbuminuria and early renal response to lethal dose Shiga toxin type 2 in rats.

Authors:  Federico Ochoa; Gisela Oltra; Elizabeth Gerhardt; Ricardo Hermes; Lilian Cohen; Alicia E Damiano; Cristina Ibarra; Nestor R Lago; Elsa Zotta
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-01-19

8.  Relevance of Bacteriophage 933W in the Development of Hemolytic Uremic Syndrome (HUS).

Authors:  Manuel E Del Cogliano; Alipio Pinto; Jorge Goldstein; Elsa Zotta; Federico Ochoa; Romina Jimena Fernández-Brando; Maite Muniesa; Pablo D Ghiringhelli; Marina S Palermo; Leticia V Bentancor
Journal:  Front Microbiol       Date:  2018-12-13       Impact factor: 5.640

Review 9.  Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.

Authors:  Chad L Mayer; Caitlin S Leibowitz; Shinichiro Kurosawa; Deborah J Stearns-Kurosawa
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

10.  Effects of Escherichia coli subtilase cytotoxin and Shiga toxin 2 on primary cultures of human renal tubular epithelial cells.

Authors:  Laura B Márquez; Natalia Velázquez; Horacio A Repetto; Adrienne W Paton; James C Paton; Cristina Ibarra; Claudia Silberstein
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.